<DOC>
	<DOCNO>NCT00161096</DOCNO>
	<brief_summary>The purpose study investigate several aspect chronic use acid suppress medication : dependence maintenance therapy , possibility on-demand use , predictor ( patient characteristic ) daily need , on-demand use termination chronic use .</brief_summary>
	<brief_title>On-Demand Use Pantoprazole : Determinants Chronic Use Acid Suppressive Medication</brief_title>
	<detailed_description>2-5 % general population chronic user acid suppress medication ( proton pump inhibitor , H2 receptor antagonist ) , mostly gastro-oesophageal reflux disease ( GORD ) . Prescription data health insurance show number chronic user increase every year , large economic consequence . There indication however on-demand intermittent therapy effective daily use . No evidence exist regard patient likely benefit intermittent , on-demand therapy even termination . In study several aspect chronic use acid suppressive therapy investigate family practice patient . Chronic user transfer pantoprazole 20 mg 4 week . Patients adequate relief symptom randomize two group period 13 week . group 1 : daily pantoprazole 20 mg , placebo on-demand ( indicative placebo-dependency ) group 2 : daily placebo , pantoprazole 20 mg on-demand ( indicative pharmacological dependency ) Patients visit research nurse begin study week 4 , 5 , 10 17 . In study look patient characteristic indicative dependency acid suppressive drug possibility reduce dose drug . Furthermore , aspect describe `` secondary outcome '' address .</detailed_description>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>male female ( nonpregnant , nonlactating ) outpatient 1875 chronic user acid suppressive therapy least 180 day last year stage 3 , 4 oesophagitis , Barrett 's oesophagus , acute peptic ulcer gastric hypersecretory condition , predominantly IBS symptom , previous gastric/oesophageal surgery , pyloric stenosis severe , unstable comorbidities alarm symptom malignancy past 5 year use NSAID , systemic glucocorticoid , Cox2 inhibitor , acetylsalicylic acid 150 mg daily , drug pHdependent absorption , anticholinergic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2004</verification_date>
	<keyword>on-demand therapy</keyword>
	<keyword>pantoprazole</keyword>
	<keyword>gastro-oesophageal reflux disease</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>acid suppression</keyword>
	<keyword>intermittent</keyword>
</DOC>